Literature DB >> 21222156

Optimum palliation of inoperable hilar cholangiocarcinoma: comparative assessment of the efficacy of plastic and self-expanding metal stents.

Ramu P Raju1, Sathya R Jaganmohan, William A Ross, Marta L Davila, Milind Javle, Gottumukkala S Raju, Jeffrey H Lee.   

Abstract

BACKGROUND: Endoscopic retrograde biliary drainage (ERBD) with plastic or self-expanding metal stents (SEMS) is often performed for palliative care for cholangiocarcinoma.
OBJECTIVE: The objective was to compare the clinical effectiveness, including stent patency, complication rate, and need for salvage percutaneous transhepatic biliary drainage, of SEMS and plastic stents.
METHODS: A total of 100 patients with inoperable cholangiocarcinoma were identified from an endoscopic database from 1/1/01 to 9/30/06 at a tertiary cancer hospital and their clinical history was retrospectively reviewed. All patients were followed to death, re-intervention, or for at least one year. Stent patency and patient survival were estimated by Kaplan-Meier analysis, supplemented by the log-rank test for comparisons between groups.
RESULTS: Forty-eight patients had SEMS placed and 52 patients had plastic stents placed. ERBD was successful in 46 (95.8%) in the SEMS group and 49 (94.2%) in the plastic group (P = 0.67). Median patency times were 1.86 months in the plastic group and 5.56 months in the SEMS group (P < 0.0001). A mean of 1.53 and 4.60 re-interventions were performed in the SEMS and plastic groups, respectively (P < 0.05). Complications occurred in 4/48 (8.3%) in the SEMS group and 4/52 (7.7%) in the plastic group (P = 0.79). Median survival was 9.08 and 8.22 months in the SEMS and plastic stent groups, respectively (P = 0.50).
CONCLUSION: Metallic stent patency was superior to that of plastic stents in all Bismuth-Corlette classifications of hilar cholangiocarcinoma with similar complication rates. SEMS seem to be cost-effective and, when feasible, should be considered as an initial intervention in patients with inoperable hilar cholangiocarcinoma.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21222156     DOI: 10.1007/s10620-010-1550-5

Source DB:  PubMed          Journal:  Dig Dis Sci        ISSN: 0163-2116            Impact factor:   3.199


  36 in total

1.  Patency of side branches after peripheral placement of metallic biliary endoprostheses.

Authors:  D A Nicholson; N Chetty; J E Jackson; M E Roddie; A Adam
Journal:  J Vasc Interv Radiol       Date:  1992-02       Impact factor: 3.464

2.  Symptom relief and quality of life after stenting for malignant bile duct obstruction.

Authors:  A B Ballinger; M McHugh; S M Catnach; E M Alstead; M L Clark
Journal:  Gut       Date:  1994-04       Impact factor: 23.059

3.  Comparative costs of metal versus plastic biliary stent strategies for malignant obstructive jaundice by decision analysis.

Authors:  K G Yeoh; M J Zimmerman; J T Cunningham; P B Cotton
Journal:  Gastrointest Endosc       Date:  1999-04       Impact factor: 9.427

4.  Randomised trial of endoscopic endoprosthesis versus operative bypass in malignant obstructive jaundice.

Authors:  J R Andersen; S M Sørensen; A Kruse; M Rokkjaer; P Matzen
Journal:  Gut       Date:  1989-08       Impact factor: 23.059

Review 5.  Hilar cholangiocarcinoma: a review and commentary.

Authors:  R S Chamberlain; L H Blumgart
Journal:  Ann Surg Oncol       Date:  2000 Jan-Feb       Impact factor: 5.344

6.  Cancer statistics, 1998.

Authors:  S H Landis; T Murray; S Bolden; P A Wingo
Journal:  CA Cancer J Clin       Date:  1998 Jan-Feb       Impact factor: 508.702

7.  Common bile duct obstruction due to malignancy: treatment with plastic versus metal stents.

Authors:  J Lammer; K A Hausegger; F Flückiger; F W Winkelbauer; R Wildling; G E Klein; S A Thurnher; L Havelec
Journal:  Radiology       Date:  1996-10       Impact factor: 11.105

8.  Cholangiocarcinoma. A spectrum of intrahepatic, perihilar, and distal tumors.

Authors:  A Nakeeb; H A Pitt; T A Sohn; J Coleman; R A Abrams; S Piantadosi; R H Hruban; K D Lillemoe; C J Yeo; J L Cameron
Journal:  Ann Surg       Date:  1996-10       Impact factor: 12.969

9.  Randomised trial of self-expanding metal stents versus polyethylene stents for distal malignant biliary obstruction.

Authors:  P H Davids; A K Groen; E A Rauws; G N Tytgat; K Huibregtse
Journal:  Lancet       Date:  1992 Dec 19-26       Impact factor: 79.321

10.  Endoscopic palliation of patients with biliary obstruction caused by nonresectable hilar cholangiocarcinoma: efficacy of self-expandable metallic Wallstents.

Authors:  John L S Cheng; Marco J Bruno; Jacques J Bergman; Erik A Rauws; Guido N Tytgat; Kees Huibregtse
Journal:  Gastrointest Endosc       Date:  2002-07       Impact factor: 9.427

View more
  27 in total

1.  Ongoing challenges in the endoscopic management of hilar cholangiocarcinoma.

Authors:  Harry R Aslanian; Priya A Jamidar
Journal:  Dig Dis Sci       Date:  2011-05       Impact factor: 3.199

2.  Biliary drainage strategy of unresectable malignant hilar strictures by computed tomography volumetry.

Authors:  Ei Takahashi; Mitsuharu Fukasawa; Tadashi Sato; Shinichi Takano; Makoto Kadokura; Hiroko Shindo; Yudai Yokota; Nobuyuki Enomoto
Journal:  World J Gastroenterol       Date:  2015-04-28       Impact factor: 5.742

3.  Are self-expandable metal stents superior to plastic stents in palliating malignant distal biliary strictures? A meta-analysis and systematic review.

Authors:  Harsha Moole; Amy Jaeger; Micheal Cashman; Fritz H Volmar; Sonu Dhillon; Mathew L Bechtold; Srinivas R Puli
Journal:  Med J Armed Forces India       Date:  2016-10-27

4.  Technical feasibility and revision efficacy of the sequential deployment of endoscopic bilateral side-by-side metal stents for malignant hilar biliary strictures: a multicenter prospective study.

Authors:  Tae Hoon Lee; Do Hyun Park; Sang Soo Lee; Hyun Jong Choi; Jun Kyu Lee; Tae Hyeon Kim; Jong Hyeok Kim; Seok Jeong; Sang-Heum Park; Jong Ho Moon
Journal:  Dig Dis Sci       Date:  2012-08-11       Impact factor: 3.199

Review 5.  Endoscopic management of hilar cholangiocarcinoma.

Authors:  Andrea Parodi; Deborah Fisher; Marc Giovannini; Todd Baron; Massimo Conio
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2012-01-24       Impact factor: 46.802

Review 6.  Endoscopic treatment options for cholangiocarcinoma.

Authors:  Linda Ann Hou; Jacques Van Dam
Journal:  Hepat Oncol       Date:  2014-03-20

Review 7.  [Diagnostics and treatment of cholangiocellular carcinoma].

Authors:  L Zender; N P Malek
Journal:  Internist (Berl)       Date:  2016-12       Impact factor: 0.743

Review 8.  Endoscopic palliation of malignant biliary strictures.

Authors:  Sanjay M Salgado; Monica Gaidhane; Michel Kahaleh
Journal:  World J Gastrointest Oncol       Date:  2016-03-15

Review 9.  Cholangiocarcinoma.

Authors:  Nataliya Razumilava; Gregory J Gores
Journal:  Lancet       Date:  2014-02-26       Impact factor: 79.321

10.  Metal stents: a bridge to surgery in hilar cholangiocarcinoma.

Authors:  Dirk J Grünhagen; Declan F J Dunne; Richard P Sturgess; Nick Stern; Stephen Hood; Stephen W Fenwick; Graeme J Poston; Hassan Z Malik
Journal:  HPB (Oxford)       Date:  2012-10-16       Impact factor: 3.647

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.